NCT00665314
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- Berlin, Germany
- Cologne, Germany
- Dresden, Germany
- Nuremberg, Germany
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
1,466 public trials
175 recruiting studies
Lymphoma trial results
NCT01168752
- Conditions
- Cancer, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
- Locations
-
- Centre Georges-François Leclerc Dijon, France
- Institut Claudius Regaud Toulouse, France
- Institut Gustave Roussy Villejuif, France
NCT00066248
- Conditions
- Astrocytoma, Blast Crisis, Body Weight, +83 more
- Locations
-
- CCOP - Bay Area Tumor Institute Oakland, California, United States
- Children's Hospital & Research Center Oakland Oakland, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- University of Florida Shands Cancer Center Gainesville, Florida, United States
Completed
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
NCT01273090
- Conditions
- Astrocytoma, Brain and Central Nervous System Tumors, Burkitt Lymphoma, +58 more
- Locations
-
- UAB Comprehensive Cancer Center Birmingham, Alabama, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
NCT00978523
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- TGen Clinical Research Services at Scottsdale Healthcare Scottsdale, Arizona, United States
- The Ohio State University - Comprehensive Cancer Center Columbus, Ohio, United States
- Royal Marsden Hospital Sutton, Surrey, United Kingdom
NCT00070447
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
- CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
NCT00727831
- Conditions
- Chemically-Induced Disorders, Chemotherapeutic Agent Toxicity, Digestive System Diseases, +20 more
- Locations
-
- Leeds General Infirmary Leeds, England, United Kingdom
- Torbay Hospital Torquay, England, United Kingdom
Completed
Radiolabeled Monoclonal Antibody in Treating Patients With Previously Treated Large Cell Lymphoma
NCT00028613
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ireland Cancer Center Cleveland, Ohio, United States
Completed
Lymphoma Follow-up
NCT00744120
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- NIA Clinical Research Unit Baltimore, Maryland, United States
NCT00071955
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
- Rush Cancer Institute at Rush University Medical Center Chicago, Illinois, United States
- Indiana University Cancer Center Indianapolis, Indiana, United States
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States